Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
View Patent ↗Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
1. A method of screening for agents that modulate Mycobacterium tuberculosis triacylglycerol hydrolase (MTTGH) comprising the steps of i) contacting a test compound with a Mycobacterium tuberculosis triacylglycerol hydrolase (MTTGH) polypeptide, and ii) detecting binding of said test compound to said MTTGH polypeptide, wherein a test compound which binds to said MTTGH polypeptide is identified as an agent for modulating the activity of Mycobacterium tuberculosis triacylglycerol hydrolase.
2. A method of screening for agents that modulate Mycobacterium tuberculosis triacylglycerol hydrolase (MTTGH) comprising the steps of i) determining the activity of a MTTGH polypeptide in the presence or in the absence of a test compound, and ii) identifying a test compound that modulates the activity of a MTTGH polypeptide as a potential agent for modulating the activity of Mycobacterium tuberculosis triacylglycerol hydrolase.
3. A method of screening for agents that modulate Mycobacterium tuberculosis triacylglycerol hydrolase (MTTGH) comprising the steps of i) determining the activity of a MTTGH polypeptide in the presence of a test compound, ii) determining the activity of a MTTGH polypeptide in the presence of a compound known to be a regulator of a MTTGH polypeptide and (iii) comparing activity of step (i) with step (ii), wherein a test compound that modulates the activity of MTTGH polypeptide is identified as an agent for modulating the activity of Mycobacterium tuberculosis triacylglycerol hydrolase.
4. The method of claim 1 , further comprising the step of obtaining a cell which has been engineered to express a MTTGH polypeptide and wherein the step of contacting is in or at the surface of said cell.
5. The method of claim 4 , wherein the cell is in vitro.
6. The method of claim 1 , wherein the step of contacting is in a cell-free system.
7. The method of claim 1 , wherein the polypeptide is coupled to a detectable label.
8. The method of claim 1 , wherein the compound is coupled to a detectable label.
9. The method of claim 1 , wherein said MTTGH polypeptide comprises a ligand bound thereto and the test compound displaces said ligand.
10. The method of claim 1 , wherein the polypeptide is aft ached to a solid support.
11. The method of claim 1 , wherein the compound is attached to a solid support.
12. A method of screening for agents that modulate Mycobacterium tuberculosis triacylglycerol hydrolase (MTTGH) comprising the steps of i) contacting a test compound with a MTTGH polynucleotide, ii) detecting binding of said test compound to said MTTGH polynucleotide, wherein a test compound that binds to said MTTGH polynucleotide is identified as a potential agent for modulating the activity of Mycobacterium tuberculosis triacylglycerol hydrolase.
13. The method of claim 12 wherein the nucleic acid molecule is RNA.
14. The method of claim 12 , further comprising the step of obtaining a cell which has been engineered to express a MTTGH polypeptide wherein the contacting step is in or at the surface of said cell.
15. The method of claim 12 wherein the contacting step is in a cell-free system.
16. The method of claim 12 wherein polynucleotide is coupled to a detectable label.
17. The method of claim 12 wherein the test compound is coupled to a detectable label.
18. A recombinant cell host containing a purified MTTGH polynucleotide or a recombinant vector comprising a MTTGH polynucleotide, wherein said MTTGH polynucleotide is SEQ. ID No. 1, or a sequence having at least 90 percent identity therewith.